1. Home
  2. KTCC vs KPTI Comparison

KTCC vs KPTI Comparison

Compare KTCC & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTCC
  • KPTI
  • Stock Information
  • Founded
  • KTCC 1969
  • KPTI 2008
  • Country
  • KTCC United States
  • KPTI United States
  • Employees
  • KTCC N/A
  • KPTI N/A
  • Industry
  • KTCC Electrical Products
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTCC Technology
  • KPTI Health Care
  • Exchange
  • KTCC Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • KTCC 34.0M
  • KPTI 33.6M
  • IPO Year
  • KTCC N/A
  • KPTI 2013
  • Fundamental
  • Price
  • KTCC $2.39
  • KPTI $4.95
  • Analyst Decision
  • KTCC
  • KPTI Strong Buy
  • Analyst Count
  • KTCC 0
  • KPTI 5
  • Target Price
  • KTCC N/A
  • KPTI $61.00
  • AVG Volume (30 Days)
  • KTCC 25.2K
  • KPTI 161.4K
  • Earning Date
  • KTCC 05-06-2025
  • KPTI 05-07-2025
  • Dividend Yield
  • KTCC N/A
  • KPTI N/A
  • EPS Growth
  • KTCC N/A
  • KPTI N/A
  • EPS
  • KTCC N/A
  • KPTI N/A
  • Revenue
  • KTCC $514,394,000.00
  • KPTI $145,237,000.00
  • Revenue This Year
  • KTCC N/A
  • KPTI $4.87
  • Revenue Next Year
  • KTCC N/A
  • KPTI $16.29
  • P/E Ratio
  • KTCC N/A
  • KPTI N/A
  • Revenue Growth
  • KTCC N/A
  • KPTI N/A
  • 52 Week Low
  • KTCC $2.21
  • KPTI $3.51
  • 52 Week High
  • KTCC $6.14
  • KPTI $21.30
  • Technical
  • Relative Strength Index (RSI)
  • KTCC 39.50
  • KPTI 48.29
  • Support Level
  • KTCC $2.25
  • KPTI $3.83
  • Resistance Level
  • KTCC $2.40
  • KPTI $4.36
  • Average True Range (ATR)
  • KTCC 0.13
  • KPTI 0.43
  • MACD
  • KTCC 0.01
  • KPTI 0.22
  • Stochastic Oscillator
  • KTCC 36.73
  • KPTI 91.72

About KTCC Key Tronic Corporation

Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: